Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota
出版年份 2021 全文链接
标题
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-12-14
DOI
10.3389/fimmu.2021.772532
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
- (2021) Se-Hoon Lee et al. Nature Microbiology
- Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade
- (2021) Wei Si et al. GUT
- Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
- (2021) Haiyan Xu et al. Nutrients
- Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
- (2021) Miles C. Andrews et al. NATURE MEDICINE
- Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel
- (2021) Kai Han et al. Nature Biomedical Engineering
- Degradation Products of Complex Arabinoxylans by Bacteroides intestinalis Enhance the Host Immune Response
- (2021) Taro Yasuma et al. Microorganisms
- Characterization of potentially probiotic lactic acid bacteria and bifidobacteria isolated from human colostrum
- (2020) Wenjun Liu et al. JOURNAL OF DAIRY SCIENCE
- Predictable modulation of cancer treatment outcomes by the gut microbiota
- (2020) Yoshitaro Heshiki et al. Microbiome
- The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
- (2020) Florent Petitprez et al. Frontiers in Immunology
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
- (2020) Zhi Peng et al. Cancer Immunology Research
- How does the gut microbiome influence immune checkpoint blockade therapy?
- (2020) Andrew A Almonte et al. IMMUNOLOGY AND CELL BIOLOGY
- The microbiome, cancer, and cancer therapy
- (2019) Beth A. Helmink et al. NATURE MEDICINE
- Isoleucine plays an important role for maintaining immune function
- (2019) Changsong Gu et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis
- (2019) Eduard Ansaldo et al. SCIENCE
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- Antibiotic therapy and outcome from immune-checkpoint inhibitors
- (2019) David J. Pinato et al. Journal for ImmunoTherapy of Cancer
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy
- (2018) Yiming Wang et al. Frontiers in Immunology
- Investigations of Bacteroides spp. towards next-generation probiotics
- (2018) Huizi Tan et al. FOOD RESEARCH INTERNATIONAL
- Breast cancer in postmenopausal women is associated with an altered gut metagenome
- (2018) Jia Zhu et al. Microbiome
- Species-level functional profiling of metagenomes and metatranscriptomes
- (2018) Eric A. Franzosa et al. NATURE METHODS
- PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
- (2018) Neda Yaghoubi et al. BIOMEDICINE & PHARMACOTHERAPY
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Antibiotic-Induced Alterations in Gut Microbiota Are Associated with Changes in Glucose Metabolism in Healthy Mice
- (2017) Richard R. Rodrigues et al. Frontiers in Microbiology
- Functional Changes in the Gut Microbiome Contribute to Transforming Growth Factor β-Deficient Colon Cancer
- (2017) Scott G. Daniel et al. mSystems
- Commensal A4 bacteria inhibit intestinal Th2-cell responses through induction of dendritic cell TGF-β production
- (2016) Wei Wu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Probiotics, gut microbiota, and their influence on host health and disease
- (2016) Borja Sánchez et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Cancer and the Immune System: Basic Concepts and Targets for Intervention
- (2015) Drew Pardoll SEMINARS IN ONCOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started